Stay updated on Seladelpar in Primary Biliary Cholangitis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.

Latest updates to the Seladelpar in Primary Biliary Cholangitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record for the completed seladelpar (MBX-8025) Phase 2 study is displayed, including eligibility criteria, treatment arms, outcome measures, study locations, and supporting documents.SummaryDifference77%

- Check18 days agoChange DetectedThe page remains a 403 Forbidden error. The footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the study record’s existing 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study record page displays a 403 Forbidden error, so its trial details are unavailable.SummaryDifference0.6%

Stay in the know with updates to Seladelpar in Primary Biliary Cholangitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.